Fujiwara, Wakako
Yotsukura, Masaya https://orcid.org/0000-0001-7012-7961
Yoshida, Yukihiro
Nakagawa, Kazuo
Kashima, Jumpei
Yatabe, Yasushi
Watanabe, Shun-ichi
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19ck0106323h003)
Article History
Received: 11 December 2023
Accepted: 9 May 2024
First Online: 29 May 2024
Disclosure
: Yasushi Yatabe has received personal fees outside of this work from MSD, Chugai Pharmaceutical, Astra Zeneca, Pfizer Japan, Roche/Ventana, Agilent/Dako, Thermo Fisher Scientific, Archer CD, Novartis Pharma, Eli Lilly Japan, Amgen, Merck Biopharma, Sysmex, Bayer, and Daiichi Sankyo. Wakako Fujiwara, Masaya Yotsukura, Yukihiro Yoshida, Kazuo Nakagawa, Jumpei Kashima, and Shun-ichi Watanabe have no conflicts of interest to declare in relation to this work.